重庆市药品监督管理局关于5批次药品不符合规定的通告

Core Viewpoint - The Chongqing Municipal Drug Administration has conducted inspections and found several traditional Chinese medicine products that do not meet regulatory standards, leading to enforcement actions against the manufacturers [3][4]. Group 1: Inspection Findings - Products from four companies were identified as non-compliant: Hawthorn from Hunan Liucheng Traditional Chinese Medicine Co., Ltd., Scorpion from Shaoyang Shennong Traditional Chinese Medicine Technology Development Co., Ltd., Cassia Seed from Yongzhou Yongdian Traditional Chinese Medicine Co., Ltd., and Poria from Chongqing Weide Pharmaceutical Co., Ltd. [3][4] - The specific non-compliance issues included various inspection criteria, with the Hawthorn and Scorpion failing checks, while the Cassia Seed and Poria were found non-compliant in specific measurement tests [3][4]. Group 2: Regulatory Actions - The Chongqing Municipal Drug Administration has mandated necessary control measures such as sealing, confiscation, suspension of sales, and recalls for the identified non-compliant products [4]. - The enforcement actions are based on relevant laws and regulations to ensure public safety in drug consumption [4].